25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Variations in the quality of tuberculosis care in urban India: A cross-sectional, standardized patient study in two cities

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          India has the highest burden of tuberculosis (TB). Although most patients with TB in India seek care from the private sector, there is limited evidence on quality of TB care or its correlates. Following our validation study on the standardized patient (SP) method for TB, we utilized SPs to examine quality of adult TB care among health providers with different qualifications in 2 Indian cities.

          Methods and findings

          During 2014–2017, pilot programs engaged the private health sector to improve TB management in Mumbai and Patna. Nested within these projects, to obtain representative, baseline measures of quality of TB care at the city level, we recruited 24 adults to be SPs. They were trained to portray 4 TB “case scenarios” representing various stages of disease and diagnostic progression. Between November 2014 and August 2015, the SPs visited representatively sampled private providers stratified by qualification: (1) allopathic providers with Bachelor of Medicine, Bachelor of Surgery (MBBS) degrees or higher and (2) non-MBBS providers with alternative medicine, minimal, or no qualifications.

          Our main outcome was case-specific correct management benchmarked against the Standards for TB Care in India (STCI). Using ANOVA, we assessed variation in correct management and quality outcomes across (a) cities, (b) qualifications, and (c) case scenarios. Additionally, 2 micro-experiments identified sources of variation: first, quality in the presence of diagnostic test results certainty and second, provider consistency for different patients presenting the same case.

          A total of 2,652 SP–provider interactions across 1,203 health facilities were analyzed. Based on our sampling strategy and after removing 50 micro-experiment interactions, 2,602 interactions were weighted for city-representative interpretation. After weighting, the 473 Patna providers receiving SPs represent 3,179 eligible providers in Patna; in Mumbai, the 730 providers represent 7,115 eligible providers. Correct management was observed in 959 out of 2,602 interactions (37%; 35% weighted; 95% CI 32%–37%), primarily from referrals and ordering chest X-rays (CXRs). Unnecessary medicines were given to nearly all SPs, and antibiotic use was common. Anti-TB drugs were prescribed in 118 interactions (4.5%; 5% weighted), of which 45 were given in the case in which such treatment is considered correct management.

          MBBS and more qualified providers had higher odds of correctly managing cases than non-MBBS providers (odds ratio [OR] 2.80; 95% CI 2.05–3.82; p < 0.0001). Mumbai non-MBBS providers had higher odds of correct management than non-MBBS in Patna (OR 1.79; 95% CI 1.06–3.03), and MBBS providers’ quality of care did not vary between cities (OR 1.15; 95% CI 0.79–1.68; p = 0.4642). In the micro-experiments, improving diagnostic certainty had a positive effect on correct management but not across all quality dimensions. Also, providers delivered idiosyncratically consistent care, repeating all observed actions, including mistakes, approximately 75% of the time. The SP method has limitations: it cannot account for patient mix or care-management practices reflecting more than one patient–provider interaction.

          Conclusions

          Quality of TB care is suboptimal and variable in urban India’s private health sector. Addressing this is critical for India’s plans to end TB by 2025. For the first time, we have rich measures on representative levels of care quality from 2 cities, which can inform private-sector TB interventions and quality-improvement efforts.

          Abstract

          Madhukar Pai and colleagues use standardized patients trained to portray symptoms of tuberculosis to assess the quality of diagnosis and care across private sector health providers in Mumbai and Patna, India.

          Author summary

          Why was this study done?
          • India accounts for a quarter of the world’s estimated 10.4 million new tuberculosis (TB) cases per year, nearly a third of the 1.7 million annual TB deaths, and a third of the estimated 4 million “missing patients” who are either not diagnosed or are not reported to national TB programs.

          • The private health sector provides the bulk of primary care in India, serving as the first point of contact for 50% to 70% of patients with TB symptoms. The private sector comprises a wide range of qualification levels: allopathic providers with Bachelor of Medicine, Bachelor of Surgery (MBBS) or higher degrees; Ayurveda, Yoga, Unani, Siddha, or Homeopathy (AYUSH) practitioners (practitioners with degrees in alternative medicine or traditional systems of health); and providers with other or no formal qualifications, who are known to provide a large proportion of primary care.

          • Little is known about quality of TB care in the private sector; however, the Government of India has prioritized the engagement of the private sector in the National Strategic Plan (NSP) for TB elimination (2017–2025).

          What did the researchers do and find?
          • In the 2 Indian cities of Mumbai and Patna, we used a list of all private-sector providers to construct a representative sample for a quality of care surveillance project using the standardized patient (SP) method.

          • During 2014–2015, the SPs—seemingly healthy adults hired locally and trained to convincingly portray symptoms of illness or test results to providers—conducted a total of 2,652 incognito visits among 1,203 health facilities. SPs portrayed cases representing 4 different stages of TB progression and diagnosis and reported the providers’ actions and prescriptions for analysis.

          • We report 4 novel findings in this publication. First, benchmarked against national and international standards of TB care, only 35% of interactions resulted in standards-compliant care during a one-time visit to a healthcare provider.

          • Second, lack of adherence to TB standards does not represent a typical “alternative” care pattern that would be appropriate for polluted urban environments because providers followed multiple different protocols.

          • Third, there is a wide range of estimated quality in each qualification stratum, and providers demonstrate consistency with their own previous behaviors.

          • Finally, providers offer more TB-focused care in cases with higher diagnostic certainty provided by the patient.

          What do these findings mean?
          • Although the SP method deployed in this study cannot account for patient mix or care-management practices reflecting more than one patient–provider interaction, we find that quality of TB care is suboptimal and variable in urban India’s private health sector. Therefore, improving quality of TB management in the private sector must be a priority for India’s TB elimination strategy.

          • With large-scale, city-level representative estimates, these findings can inform specific efforts for private-sector TB interventions and quality improvement.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          The population dynamics and control of tuberculosis.

          More than 36 million patients have been successfully treated via the World Health Organization's strategy for tuberculosis (TB) control since 1995. Despite predictions of a decline in global incidence, the number of new cases continues to grow, approaching 10 million in 2010. Here we review the changing relationship between the causative agent, Mycobacterium tuberculosis, and its human host and examine a range of factors that could explain the persistence of TB. Although there are ways to reduce susceptibility to infection and disease, and a high-efficacy vaccine would boost TB prevention, early diagnosis and drug treatment to interrupt transmission remain the top priorities for control. Whatever the technology used, success depends critically on the social, institutional, and epidemiological context in which it is applied.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Totally drug-resistant tuberculosis in India.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade.

              Despite the high coverage of directly observed treatment short-course (DOTS), tuberculosis (TB) continues to affect 10.4 million people each year, and kills 1.8 million. High TB mortality, the large number of missing TB cases, the emergence of severe forms of drug resistance, and the slow decline in TB incidence indicate that merely expanding the coverage of TB services is insufficient to end the epidemic. In the era of the End TB Strategy, we need to think beyond coverage and start focusing on the quality of TB care that is routinely offered to patients in high burden countries, in both public and private sectors. In this review, current evidence on the quality of TB care in high burden countries, major gaps in the quality of care, and some novel efforts to measure and improve the quality of care are described. Based on systematic reviews on the quality of TB care or surrogates of quality (e.g., TB diagnostic delays), analyses of TB care cascades, and newer studies that directly measure quality of care, it is shown that the quality of care in both the public and private sector falls short of international standards and urgently needs improvement. National TB programs will therefore need to systematically measure and improve quality of TB care and invest in quality improvement programs.
                Bookmark

                Author and article information

                Contributors
                Role: Data curationRole: Formal analysisRole: MethodologyRole: Project administrationRole: SupervisionRole: Writing – original draftRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: MethodologyRole: SupervisionRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: Writing – review & editing
                Role: Data curationRole: ValidationRole: Writing – review & editing
                Role: Data curationRole: ValidationRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: Writing – review & editing
                Role: Data curationRole: Project administrationRole: Writing – review & editing
                Role: MethodologyRole: SupervisionRole: Writing – review & editing
                Role: Data curationRole: MethodologyRole: SupervisionRole: Writing – review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: SupervisionRole: Writing – review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: Writing – review & editing
                Role: Academic Editor
                Journal
                PLoS Med
                PLoS Med
                plos
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, CA USA )
                1549-1277
                1549-1676
                25 September 2018
                September 2018
                : 15
                : 9
                : e1002653
                Affiliations
                [1 ] Development Research Group, The World Bank, Washington, District of Columbia, United States of America
                [2 ] University of California at Berkeley, Berkeley, California, United States of America
                [3 ] Institute for Socio-Economic Research on Development and Democracy, Delhi, India
                [4 ] Center for Operational Research, International Union Against TB and Lung Diseases, Paris, France
                [5 ] Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America
                [6 ] Centre National de la Recherche Scientifique, Paris, France
                [7 ] ACCESS Health International, New York, New York, United States of America
                [8 ] Department of Anthropology, Johns Hopkins University, Baltimore, Maryland, United States of America
                [9 ] Center for Policy Research, New Delhi, India
                [10 ] McGill International TB Centre, McGill University, Montreal, Canada
                [11 ] Manipal McGill Centre for Infectious Diseases, Manipal Academy of Higher Education, Manipal, India
                Universidad Peruana Cayetano Heredia, PERU
                Author notes

                We have read the journal’s policy, and the authors of this manuscript have the following competing interests: MP is a member of the Editorial Boards of PLOS Medicine and PLOS ONE and is also an editor of the PLOS Tuberculosis Channel. MP previously served as a consultant to the Bill & Melinda Gates Foundation. The other authors have no competing interests to declare.

                ‡ These authors are joint senior authors on this work.

                Author information
                http://orcid.org/0000-0003-4889-9433
                http://orcid.org/0000-0001-9652-6653
                http://orcid.org/0000-0002-2063-943X
                http://orcid.org/0000-0003-3667-4536
                Article
                PMEDICINE-D-18-00953
                10.1371/journal.pmed.1002653
                6155454
                30252849
                949d1434-89af-44a5-b471-f9f4b610bcbd
                © 2018 Kwan et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 9 March 2018
                : 15 August 2018
                Page count
                Figures: 4, Tables: 2, Pages: 22
                Funding
                Funded by: funder-id http://dx.doi.org/10.13039/501100004828, Grand Challenges Canada;
                Award ID: S5 0373-01
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000865, Bill and Melinda Gates Foundation;
                Award ID: OPP1091843
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100004421, World Bank Group;
                Award ID: Knowledge for Change Program, and the World Bank Development Research Group
                Award Recipient :
                Funded by: Center for Operational Research, The Union
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000865, Bill and Melinda Gates Foundation;
                Award ID: OPP1154665
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000862, Doris Duke Charitable Foundation;
                Award Recipient :
                Funded by: Havard Center for AIDS Research
                Award ID: 5P30AI060354-13
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100007299, Harvard Catalyst;
                Award ID: KL2 TR001100
                Award Recipient :
                This study was funded by Grand Challenges Canada (S5 0373-01), the Bill & Melinda Gates Foundation (OPP1091843), and the Knowledge for Change Program at the World Bank. SS is supported by the Center for Operational Research, The Union (Paris, France). RS is supported by a grant from the Bill & Melinda Gates Foundation via the Arcady group (OPP1154665) and a Doris Duke Clinical Scientist Development Award, and acknowledges prior support from a Harvard Center for AIDS Research (5P30AI060354-13) and a Harvard Catalyst KL2/CMERIT Award (KL2 TR001100). MP is a recipient of a Tier 1 Canada Research Chair from Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Medicine and Health Sciences
                Infectious Diseases
                Bacterial Diseases
                Tuberculosis
                Medicine and Health Sciences
                Tropical Diseases
                Tuberculosis
                Biology and Life Sciences
                Anatomy
                Body Fluids
                Mucus
                Sputum
                Medicine and Health Sciences
                Anatomy
                Body Fluids
                Mucus
                Sputum
                Biology and Life Sciences
                Physiology
                Body Fluids
                Mucus
                Sputum
                Medicine and Health Sciences
                Physiology
                Body Fluids
                Mucus
                Sputum
                Medicine and Health Sciences
                Health Care
                Quality of Care
                Medicine and Health Sciences
                Diagnostic Medicine
                Tuberculosis Diagnosis and Management
                Medicine and Health Sciences
                Pharmacology
                Drugs
                Antimicrobials
                Antibiotics
                Biology and Life Sciences
                Microbiology
                Microbial Control
                Antimicrobials
                Antibiotics
                Medicine and Health Sciences
                Diagnostic Medicine
                Biology and Life Sciences
                Organisms
                Bacteria
                Actinobacteria
                Mycobacterium Tuberculosis
                Biology and Life Sciences
                Physiology
                Physiological Processes
                Coughing
                Medicine and Health Sciences
                Physiology
                Physiological Processes
                Coughing
                Medicine and Health Sciences
                Diagnostic Medicine
                Signs and Symptoms
                Coughing
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Signs and Symptoms
                Coughing
                Custom metadata
                The data and analysis code is available at https://github.com/qutubproject/plosmed2018.

                Medicine
                Medicine

                Comments

                Comment on this article